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Peste des petits ruminants is a viral disease of sheep and goats that has spread through most of Africa as well as
the Middle East and the Indian subcontinent. Although, the spread of the disease and its economic impact has
made it a focus of international concern, relatively little is known about the nature of the disease itself. We have
studied the early stages of pathogenesis in goats infected with six different isolates of Peste des petits ruminants
virus representing all four known lineages of the virus. No lineage-specific difference in the pathogenicity of the virus
isolates was observed, although there was evidence that even small numbers of cell culture passages could affect the
degree of pathogenicity of an isolate. A consistent reduction in CD4+ T cells was observed at 4 days post infection
(dpi). Measurement of the expression of various cytokines showed elements of a classic inflammatory response but also
a relatively early induction of interleukin 10, which may be contributing to the observed disease.Introduction
Peste de petits ruminants virus (PPRV) is a paramyxo-
virus that belongs to the genus Morbillivirus. It is widely
distributed in Africa, the Middle East and Asia, and has
a major economic impact on livestock keepers in devel-
oping countries, causing a severe disease in small rumi-
nants (sheep and goats), livestock animals that are often
the prerogative of the poorer groups in these countries,
especially women [1]. The virus has been spreading con-
tinuously in recent decades [2], and is beginning to re-
ceive significant attention in an effort to control and
possibly even eradicate the disease [3,4].
Despite the economic and social importance of PPR as
a disease, and a number of recent publications discuss-
ing potential new vaccines, the disease itself has not
received very close attention. There were extensive de-
scriptions of the clinical signs typical of PPRV infection
in the period when the disease was first recognised
(reviewed in [5]), as well as descriptions of the identifica-
tion of the disease in various regions or in specific wild-
life species. There have also been reports that, in some
cases, specific breeds of goats may be more susceptible
than others [6] and that goats may be more susceptible,
or develop more severe pathology, than sheep [7-9].
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unless otherwise stated.causes of pathology, apart from a recent thorough histo-
logical investigation of the distribution of the virus dur-
ing the early stages of infection [10], which showed that
the virus spread in a similar way to measles virus spread
in humans [11,12], and a study of interleukin 4 (IL-4)
and gamma interferon (IFNγ) induction during PPRV in-
fection [13]. In most cases, the studies have used one
strain of virus in one host species, making comparisons
more difficult. We have carried out a study in goats of
the effects of six wild-type isolates, both recent and ar-
chived, including representative isolates of all four line-
ages, examining the clinical picture, the replication of
the virus and the effects of the infection on a broad
spectrum of cytokines. We found that the clinical pic-
ture was not linked to specific lineages, although some
isolates were slightly more pathogenic than others. In
addition we observed changes in cytokine mRNA levels
that matched the expected picture of an inflammatory
disease, with the addition of an early increase in IL-10
transcripts, suggesting this cytokine may play a role in
the subsequent pathogenic effects observed.
Materials and methods
Cells and viruses
The PPRV isolates used (Table 1) were grown and titred
on Vero cells expressing the canine signalling lympho-
cyte activation molecule (SLAM) (Vero-dog-SLAM
cells) [14]. Cells, media and foetal calf serum were freetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Virus isolates used in the study
Goats Virus Lineage Passage history1
1-3 Kurdistan/2011 4 CVS1 VDS2
4-6 Sudan/Sinnar/72 3 BK2 LK2 V2 VDS1
7-9 Ghana/78 2 LK1 V1 VDS1
10-12 Nigeria/76 2 BK6 V3 VDS1
13-15 Ivory Coast/89 1 VDS1
16-18 Guinea-Bissau/91 1 V5 VDS1
1Cell types used were: CVS, CV1 expressing goat SLAM; VDS, Veros expressing
dog SLAM; V, Vero; BK, primary bovine kidney; LK, primary lamb kidney.
Baron et al. Veterinary Research 2014, 45:22 Page 2 of 11
http://www.veterinaryresearch.org/content/45/1/22from adventitious agents such as pestiviruses. All vi-
ruses were archived virus stocks held at the Pirbright
Institute Reference Laboratory with the exception of
PPRV Kurdistan/2011, which was the kind gift of Dr
Bernd Hoffman, FLI, Germany. All the virus stocks used
were checked by real-time PCR and shown to be without
detectable contamination with any serotype of bluetongue
virus (assay carried out by the EU Reference Laboratory
for BTV) or any pestivirus (using the pan-pestivirus
primers originally described by Vilcek et al. [15]).
Animal studies
The animal study was carried out in the Pirbright institute
high containment isolation units under the auspices of
relevant UK legislation. The work was covered by a pro-
ject licence issued by the UK Home Office and all staff
carrying out procedures on animals had appropriate per-
sonal licences. The work was reviewed and approved by
the Pirbright Institute Animal Welfare and Ethical Review
Body. Outbred British male goats, 10-13 months in age,
were infected with 105 TCID50 of PPRV in a final volume
of 1 mL, diluted in PBS where required (Kurdistan/2011,
which only grew to a titre of 105 TCID50/mL, was used
undiluted). Three goats were inoculated with each PPRV
isolate. The first two animals in each group were given the
virus as a subcutaneous injection, while the third animal
received the virus intranasally using a syringe-mounted
Mucosal Atomiser Device (MAD 300, LMA, USA)).
Blood samples were taken from a superficial vein into
vacutainers prepared for serum or containing heparin
or EDTA (Becton-Dickinson) or for subsequent RNA
isolation (Tempus Blood RNA Tubes, Life Technologies).
The rectal temperature of the animals was determined
daily for 3 days prior to infection and for up to 21 days
post infection (dpi). White cell counts were determined
from anti-coagulant (EDTA)-treated blood.
Other assays
Isolation of RNA from blood samples and real-time PCR
assay of PPRV genome was carried out on anticoagulant
(EDTA)-treated blood as previously described [16].Isolation of RNA from blood collected in Tempus tubes
and subsequent real-time PCR assay of goat cytokine
and housekeeping gene mRNAs was carried out essen-
tially as described [17], except that the primers and an-
nealing temperatures used were those indicated in
Table 2. The threshold cycle (Ct) for each assay for each
animal was the mean of triplicates, and was normalised
using the mean Ct for three housekeeping genes (glycer-
aldehyde phosphate dehydrogenase (GAPDH), succinate
dehydrogenase A (SDHA) and glucose 6 phosphate de-
hydrogenase (G6PD)).
For the determination of numbers of different blood
cell types by flow cytometry, heparinised blood was
stained with antibodies for surface markers CD4, CD8,
CD14 and WC1. Live cells were stained using Live/dead
Aqua (Life Technologies). Monoclonal antibody to CD4
was conjugated to allophycocyanin (APC) (clone 44.38,
MCA2213A647 from Serotec) while anti-CD8 was
conjugated to R-phycoerythrin (R-PE) (clone CC63,
MCA837 from Serotec). Anti-CD14 (clone CCG33) and
anti-WC1, a marker for γδ T cells (clone 197) were pro-
vided as hybridoma supernatant by the Microbiological
Services division of the Pirbright Institute, and were
directly conjugated to R-PE and APC respectively, using
Zenon® kits (Life Technologies). Red blood cells were
lysed using BD FACS Lysis solution (BD Biosciences).
Labelled cells were fixed in 4% paraformaldehyde
(PFA). Cells were analysed using the LSR Fortessa (BD
Biosciences). The BD Biosciences DIVA software was
used to acquire the data and FCS Express 3 (De Novo
Software) or FlowJo (Tree Star Inc.) used for analysis.
Changes in the composition of the lymphocytes were
analysed for statistical significance using one-way ANOVA
and Tukey’s correction for multiple comparisons (Graph-
Pad Prism).
Statistical analysis of other data from the animal ex-
periment was performed using a mixed model ANOVA
as implemented in Minitab 16, with the virus used and
the days post infection fixed factors and the animals in
each group as random factors. The significance of any
increase or decrease of transcription on day 2, 4 and 6,
compared to the value at day zero, was determined using
Dunnett’s correction for multiple comparisons.
Results
We selected six isolates of PPRV that had either been
stored lyophilised at the Institute soon after isolation or
had been isolated from a recent outbreak. Each virus
isolate was grown through one passage on Vero cells
expressing the canine version of the generally con-
served morbillivirus receptor, SLAM (CD150) [20].
Vero-dog-SLAM (VDS) cells [14] have proven to be a
very good host for the growth of wild-type PPRV in our
laboratory. The titre of each virus stock was determined
Table 2 PCR primer pairs and reaction conditions used in the work described in this paper
Target Primer sequences Ta1 [Primer]2 Reference
IL-1β CCTTGGGTATCAGGGACAA 60 200 nM This paper
GGGTATGGCTTTCTTTAGG
IL-4 ACCTGTTCTGTGAATGAAGCCAA 61 300 nM This paper
CTTCATAATAGTCTTTAGCCTTTC
IL-6 TCCAGAACGAGTTTGAGG 60 400 nM [18]
CATCCGAATAGCTCTCAG
IL-8 ATGAGTACAGAACTTCGA 52 300 nM [18]
TCATGGATCTTGCTTCTC
IL-10 TGCTGTTGACCCAGTCTCTG 60 200 nM [17]
AGGGCAGAAAACGATGACAG
IL-12A GGGCATTGTCTGGCTTCTG 60 200 nM This paper
TTCTTCCAGGGAGGGTTTCT
IL-12B GCTGGGAGTACCCTGACACG 63 200 nM [19]
GTGACTTTGGCTGAGGTTTGGTC
IL-18 ACTGTTCAGATAATGCACCCCAG 60 300 nM [19]
TTCTTACACTGCACAGAGATGGTTAC
Interferon β CCAGATGGTTCTCCTGCTGTGT 60 300 nM [17]
GACCAATACGGCATCTTCCTTC
TNFα GGAATACCTGGACTATGCTGA 60 300 nM This paper
CCTCACTTCCCTACATCCCT
TGFβ GGACATTAACGGGTTCAGTTC 57 200 nM This paper
GTCCAGGCTCCAGATGTAAG
Interferon γ CTCCGGCCTAACTCTCTCCT 60 300 nM [17]
AGGCCCACCCTTAGCTACAT
GAPDH GGTGATGCTGGTGCTGAGTA 60 300 nM [18]
TCATAAGTCCCTCCACGATG
SDHA ACCTGATGCTTTGTGCTCTGC 60 200 nM [18]
CCTGGACGGGCTTGGAGTAA
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on VDS cells are at least 10 times higher than the titre
of the same virus stock on unmodified Veros. Eighteen
goats were infected in groups of three with one of the
six isolates, listed in Table 1, and the animals monitored
for up to 21 days, or until the pre-defined humane end
point was reached. For the studies described here, each
animal was compared to itself at day zero. One animal
in each group was infected intranasally and the other
two by the more conventional subcutaneous route. No
difference was observed in the onset or severity of dis-
ease between the two routes of infection.
The infected goats in this study began to show clinical
signs of disease, primarily congestion of the conjunctivaand/or nasal cavity, as early as 2 dpi (Figure 1); all the
animals showed some ocular or nasal signs by 4 dpi
(Table 3). Animals began to show nasal and/or ocular
discharge at day 6. At 7 dpi, some animals began to
reach the humane end point of the protocol licence,
and had to be euthanised. Pyrexia was detectable in a
few animals at 3 dpi, rising to a peak temperature in all
animals at 5–6 dpi (Figure 2). Animals that survived
past 9 dpi showed gradually decreasing pyrexia and
other clinical signs.
All the infected animals developed leukopenia to a
greater or lesser degree, with up to 80% reduction
in white cell counts in peripheral blood (Figure 3).
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Figure 1 Clinical scores of individual animals infected with different PPRV isolates. Groups of three animals were inoculated as described
in the text with 105 TCID50 of (A) Kurdistan/2011, (B) Sudan/Sinnar/72, (C) Ghana/78, (D) Nigeria/76, (E) Ivory Coast/89, (F) Guinea-Bissau/91. The
score for each animal was determined based on the observations recorded in Table 3.
Table 3 Days post infection when different clinical signs of disease were recorded on each goat
Goat Ocular Nasal Oral Oral Diarrhoea Cough Apathy
Congestion +discharge Congestion +discharge Congestion Lesions
1 4-6 7 4 5 6 7 7 6 7
2 4-7 4-7 7 6 7
3 2-6 7 2-5 6 7 7 7 6 7
4 4-10 4-10 10 6 8 9
5 2-7 9 11-16 8 10 4-7 16 8-15 15 10-12
6 4-7 9-16 8 4 5 16 6-15 9 8 8 9 10 10
7 4-7 8 4-7 8 8 6-8 8
8 4-9 4 5 6-9 9 7 8 6 8 9 7
9 4-6 4 5 6 5 6 5 6
10 4-12 4 5 11-15 6-10 8 11 12
11 2-8 4-7 8 5-8
12 2-17 2-7 11-19 8-10 8 4-8 10 11
13 4-7 2-6 7 7 6 7 6 7
14 2-7 2-6 7 7 6 7
15 2-6 4 5 6 4-6
16 5-8 7 8 6-8
17 2 5-10 5-9 10 10 10
18 6-10 6-13 7 8
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Figure 2 Rectal temperature of individual animals infected with different PPRV isolates. Groups of three animals were inoculated as
described in the text with 105 TCID50 of (A) Kurdistan/2011, (B) Sudan/Sinnar/72, (C) Ghana/78, (D) Nigeria/76, (E) Ivory Coast/89, (F) Guinea-
Bissau/91. The temperature was determined daily, beginning 3 days before infection (to determine the baseline body temperature).
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count at 2 dpi. The leukopenia persisted beyond the
course of the study in animals that survived infection
and which could therefore be monitored through to 21
dpi. This is in contrast to other clinical signs, which de-
veloped at the same time as or after the decrease in
white cell count and which resolved more rapidly. There
was a slight correlation between the degree of disease
(clinical score) and the final loss of white cells, though it
was not marked. Interestingly, all the animals infected
with the Sudan/Sinnar/72 isolate showed an initial in-
crease in white cell count at 2 dpi, but the white cell
count then decreased to about 40% of the initial value
with a similar time course to that seen in the other in-
fected animals. It is not clear why this isolate induced
such a marked effect on white cell count. However, it ispossible that leucocytosis is also occurring in the other
infected animals at this early stage of infection (e.g. a
slight leucocytosis was seen in goat 14 infected with the
otherwise pathogenic Ivory Coast/89 isolate), but that
this has been hidden by the contrary effect (reduction in
circulating white cells). The observations in the Sudan/
Sinnar/72 group of animals are unlikely to be because
this isolate had developed a high concentration of de-
fective interfering (DI) particles in cell culture passage,
as DIs would be likely to lead to a more rapid induction
of type I interferon [21], which would result in a reduc-
tion, not an increase, of white cells [22-24]. It is also not
a reaction to the culture medium containing the virus,
as goats 1–3 received a much larger dose of medium
(since this isolate grew to a lower titre than the other
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Figure 3 White cell counts of individual animals infected with different PPRV isolates. Groups of three animals were inoculated as
described in the text with 105 TCID50 of (A) Kurdistan/2011, (B) Sudan/Sinnar/72, (C) Ghana/78, (D) Nigeria/76, (E) Ivory Coast/89, (F) Guinea-
Bissau/91. White cell counts in peripheral blood were determined on each day that blood was sampled and plotted as the percent of the initial
(day 0) value to allow for variation between individual animals.
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CD14+ monocytes and WC1+, CD4+ and CD8+ T cells in
peripheral blood following infection showed only a tran-
sient reduction in the proportion of CD4+ cells at 4 dpi
(Figure 4). No change was seen in the % of total lympho-
cytes that were CD8+ or CD14+ at any time point,
whereas the % CD4+ decreased by about 60% at 4 dpi;
this decrease was statistically significant (p < 0.01). The
apparent recovery of the % of cells that were CD4+ cells
at 7 dpi, in the absence of recovery of white cell count
in general, suggests that there was an early loss of CD4+
cells followed by a subsequent loss of other cell types.
This contrasts with a study of circulating lymphocytes in
children infected with measles, where the CD4+/CD8+
ratio was still decreased in infected subjects at up to
1 month following infection [25]. No change was ob-
served in this study in the percent of lymphocytes that
were WC1+ (γ/δ T cells) between days 2 and 9 post in-
fection, although data for this marker was not acquired
on day 0 (not shown).
The level of viraemia was estimated by real-time PCR
for the PPRV genome. All the viruses, with the exception
of the Guinea-Bissau/91 isolate, showed clear viraemia
at 4 dpi, rising to a peak at 6–7 dpi (Figure 5). The vir-
aemia appears to be prolonged, with virus still detectable
in the blood up to 21 dpi, though again the Guinea-Bissau isolate appears to differ from the others tested, in
that the one animal that survived (goat 18) showed only
low levels of viral genome in the blood at any time
point, and none at all at 21 dpi. Interestingly, this animal
showed similar leukopenia, though a reduced clinical
score profile and a delayed pyrexia, compared to other
infected animals.
The effects of infection on the expression of various
cytokines was assessed using real-time PCR assays tar-
geted to caprine cytokine mRNA sequences (Table 2).
Assays were carried out only for days 0–6 dpi when all
animals were still alive and a complete data set was
available. No significant difference was seen between
virus isolates for any cytokine. No effect was seen on
TNFα expression at any time point. There was a slight
but significant decrease in transcription of IL-18 and
TGFβ at 6 dpi (Figure 6). Transcription of IFNβ and
IFNγ was raised at 2 dpi and 4 dpi, although transcrip-
tion of both was falling again at 6 dpi, when clinical
signs were still increasing in severity. Transcription of
IL-4 was initially increased (at 2 dpi), but then fell to
below normal levels by 6 dpi. This initial rise and then
fall of transcription is similar to that previously reported
for IL-4 in Indian hill goats infected with pathogenic
PPRV [13]. IL-1β, IL-8 and IL-10 were increased at 4 dpi





























































Figure 4 Effects of PPRV infection on circulating immune cells. Goats were infected with different PPRV isolates as described in the text.
Whole blood was taken from infected animals at the indicated days post infection and was stained with monoclonal anti-CD4, anti-CD8 and
anti-CD14 monoclonal antibodies. Results are expressed as the mean ± SD of the percentage of total lymphocytes that were (A) CD14+, (B) CD4+
or (A) CD8+ cells in peripheral blood. * = p < 0.01 (not different from day zero).
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transcription of IL-8 was still increasing at 6 dpi. Inter-
estingly, IL-12A, the p37 subunit of IL-12, was clearly
induced, as expected, at 4 dpi, but had fallen to near
normal levels by 6 dpi. In contrast, the transcription of
IL-12B (the p40 subunit of IL-12, which also functions
as a component of IL-23) was still high at 6 dpi. IL-10
transcription was significantly increased by 4 dpi, which
may explain the observed decrease in IL-12 expression,
and hence also the consequent decrease in IFNγ expres-
sion [26].
Discussion
Several recent papers have commented on a reputed dif-
ficulty in reproducing PPR disease in experimental ani-
mals (e.g. [10,27]), while other investigators have
apparently found little difficulty in eliciting severe dis-
ease (e.g. [6,28,29]. One of the purposes of this study
was to establish a clear model of PPRV disease in UK
goats. Despite their different lineages and isolation date
or route of infection, all the viruses used in this study in-
duced similar clinical signs of disease, although there
was enough variation in the degree of severity of the
signs that some groups of animals had to be euthanised
by 7 dpi, whereas in other groups one or two animals
survived (Figure 1). Groups 1, 3 and 5 showed higherpeak clinical scores (Figure 1) and higher peak viraemia
(Figure 5) than groups 2, 4 and 6, and all the animals in
these groups were euthanised by day 9. No difference
was seen in the peak leukopenia (Figure 3) or pyrexia
(Figure 2) between the two groups that were all eutha-
nised by 9 dpi and those where some animals survived.
The disease in the British goats appears therefore to be
less variable than in West African dwarf goats [6], where
disease varied from peracute (death in 5–6 days) to mild
when animals were infected with a similar selection of
isolates of different lineages. In that case, the authors
speculated that severe disease may be linked to pre-
existing inapparent infections such as heartwater disease
[6], which would not be a problem with the animals
used in this study.
A previous study [27] reported that, in Alpine goats,
intranasal infection with a recent Moroccan isolate of
PPRV was found to give more rapid onset and more se-
vere disease than subcutaneous infection with the same
isolate. In the current study, comparing across all PPRV
isolates (12 animals infected subcutaneously and 6 ani-
mals infected intranasally), no statistically significant dif-
ference was seen in the clinical signs of disease induced
by the two routes of infection. There are several possible
reasons for the difference in the observations in the two
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Figure 5 PPRV-specific RNA detected in the blood of individual animals infected with different PPRV isolates. Groups of three animals
were inoculated as described in the text with 105 TCID50 of (A) Kurdistan/2011, (B) Sudan/Sinnar/72, (C) Ghana/78, (D) Nigeria/76, (E) Ivory Coast/89,
(F) Guinea-Bissau/91. Real-time PCR was carried on RNA extracted from whole blood as described in Methods. The real-time PCR values for each animal
on each day are plotted as 40-(observed Ct).
Baron et al. Veterinary Research 2014, 45:22 Page 8 of 11
http://www.veterinaryresearch.org/content/45/1/22intranasal delivery may affect exactly where in the naso-
pharyngeal tract the virus is absorbed and hence how
rapidly the virus reaches the lymph tissue where it ini-
tially replicates [10]. It is also possible that there are dif-
ferences in the rate of uptake of virus through the
subcutaneous tissues of the Alpine and UK breeds of
goats, or even differences in the preference of the Mo-
roccan isolate for cells of the nasopharyngeal mucosa. It
is clear from other previous studies that subcutaneous
infection can lead to very rapid and severe PPR disease
(e.g. [6]), and the observations in these different studies
underline the necessity of comparing virus virulence be-
tween different host species, as well as comparison of
different virus isolates in the same host species.
The early decrease of IL-12 expression may be related
to the observed decrease in transcription of IFNγ at this
time, since IL-12 is required for the production of IFNγ
in NK cells [26,30,31] as well as the long-term mainten-
ance of the T cell IFNγ response [32,33], while IL-12
synthesis is primed by IFNγ [34,35]. It may also be sig-
nificant for the progression of disease that transcription
of IL-12B was still high at 6 dpi, while transcription of
the p37 subunit had fallen, suggesting that the infected
animals may develop an excess of the p40 subunit,
which would lead to formation of homodimers of thisprotein. Such homodimers have been shown to act as
antagonists of IL-12 (reviewed in [36]), and this may
have an additional modulating action on the immediate
immune response to infection. It should be noted that
studies on the related morbillivirus measles virus have
shown that IL-12 production is inhibited during and
after infection with this virus [37-39]. Inhibition of IL-12
induction has been proposed as being responsible for
the immunosuppression seen in all morbillivirus infec-
tions, although this inhibition appears to be only one
element in a multifactorial effect [40].
The relatively early increase in IL-10 transcription may
also be playing a role in PPR pathogenesis. The role of
IL-10 in disease differs for different viruses. IL-10 pro-
duction is observed only at later stages in mice infected
with respiratory syncytial virus (RSV), and its expression
is associated with viral clearance, while the absence of
IL-10 leads to more severe disease [41]. In contrast,
acute infection of mice with influenza A virus is en-
hanced by IL-10, and clearance enhanced by its absence
[42]; similarly, IL-10 is important for the pathogenesis of
West Nile virus [43], and is associated with pathogenic
disease caused by Dengue virus [44]. Mistimed IL-10
responses can inhibit the pro-inflammatory response,



































































































































Figure 6 Changes in cytokine mRNA transcription in goats infected with PPRV. Animals were infected with different PPRV isolates as
described in Figure 1. The changes in transcription of mRNA for various cytokines was determined for each experimental animal over the first six
days of the study and are plotted as –ΔCt from day zero, so that an increase in mRNA appears as an increase in the value plotted. Stars indicate
days on which the transcription of that cytokine was significantly different from day zero. Bars are colour-coded as in Figures 1–5 to indicate the
different PPRV isolates used.
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of IL-10 may therefore contribute to the general im-
mune suppression seen in PPRV infection. Strong induc-
tion of IL-10 by 4 dpi was also seen in sheep infected
with pathogenic, but not apathogenic, Nairobi sheep dis-
ease virus [17]. It is not possible to say at this stage
whether the observed induction of IL-10 is a cause orconsequence of the pathogenic effect of virus infection
in these animals. In the study reported here, we did no-
tice that the isolate of PPRV that caused the least disease
in these studies (Guinea-Bissau/91) showed as strong an
induction of IL-10 as the other isolates, which would
argue against disease in PPRV infection being specifically
associated with IL-10 expression, but rather that this is
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the cytokines whose expression in blood cells was mea-
sured showed any distinction between the more patho-
genic viruses (groups 1, 3 and 5) and the less pathogenic
(groups 2, 4 and 6), suggesting that all the virus isolates
are causing essentially the same disease, with the differ-
ence being one of degree rather than qualitative. It will
be very interesting to compare these observations with
similar studies of PPRV infection in animals such as cat-
tle which normally do not show disease when exposed
to this virus.
No significant difference was seen in clinical signs, vir-
aemia or cytokine induction between individual lineages
of PPRV. Where two viruses from the same lineage were
used (group 3 vs 4 and group 5 vs 6), in each case one
isolate was of the more pathogenic group and one from
the less pathogenic. It seems likely that individual iso-
lates from any lineage may be more or less pathogenic.
The clearest difference between the isolates that showed
the most pathogenicity in this study and those that elic-
ited a milder disease was the number of prior passages
in cell culture, with the less pathogenic isolates having at
least 5 passages in non-SLAM bearing cells. This sug-
gests that it would be advisable for comparisons of the
virulence of different PPRV strains to take into account
even small differences in the passage history of the
isolate.
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